Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GlaxoSmithKline to buy vaccine developer with 'potentially disruptive technology' in deal worth up to $3.3B

By: via Business Journals
The deal puts GSK in a stronger position to compete with Pfizer and Merck, which are also active in vaccine development.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.